Skip to main content
Clinical Trials/EUCTR2010-023240-33-GB
EUCTR2010-023240-33-GB
Active, not recruiting
Phase 1

Post-operative pain in children with cerebral palsy following major hip surgery: a double blind randomised placebo controlled trial of pre-operative Botulinum toxin type A. [The Post-Operative Pain in cerebral Palsy (POPPIES) trial] - The Post-Operative Pain in cerebral Palsy (POPPIES) trial

Guys and St Thomas' NHS Foundation Trust0 sites54 target enrollmentMarch 2, 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Post Operative Pain in Cerebral Palsy
Sponsor
Guys and St Thomas' NHS Foundation Trust
Enrollment
54
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 2, 2011
End Date
January 7, 2015
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Guys and St Thomas' NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\.The child has displaced hips requiring bony orthopaedic surgery (osteotomy) due to cerebral palsy.
  • 2\.The child is between the ages of 2 and 18 years.
  • 3\.The child has a GMFCS level of IV or V
  • 4\.The child has a diagnosis of hypertonic cerebral palsy (or a diagnosis consistent with this nomenclature)
  • 5\.The child does not communicate verbally
  • 6\.Informed consent to participate has been given by parent/carer.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\.The child is younger than 2 years or older than 18 years
  • 2\.The child has an acute and current systemic infection or illness
  • 3\.The child has had botulinum toxin injections within the past 4 months
  • 4\.The child has had a previous reaction to botulinum toxin
  • 5\.The child has received or is likely to receive, at the time of trial drug or placebo administration, medications which might interact with botulinum toxin (this does not apply to any drugs at present)
  • 6\.Insufficient understanding of the trial by the parent or carer, in the investigator’s opinion.

Outcomes

Primary Outcomes

Not specified

Similar Trials